SHAREBASED COMPENSATION

9 Months Ended

Sep. 30, 2022

SHAREBASED COMPENSATION

Note 9 - Share-based Compensation

NOTE 10 – SHARE-BASED COMPENSATION

For share-based awards granted, we have recognized compensation expense based on the estimated grant date fair value method.  For these awards we have recognized compensation expense using a straight-line amortization method reduced for estimated forfeitures.  

The impact on our results of operations of recording share-based compensation, net of forfeitures, for the three and nine months ended September 30, 2022 and 2021, respectively, were as follows:

	Three Months Ended				Nine Months Ended
	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
(in thousands)
Cost of goods sold	$	18	$	16	$	58	$	42
Research and development		58		66		191		238
Selling, general and administrative		188		198		686		680
Total share-based compensation	$	264	$	280	$	935	$	960

Equity awards granted during the three and nine months ended September 30, 2022 and 2021 were as follows:

	Three Months Ended				Nine Months Ended
	September 30, 2022		September 30, 2021		September 30, 2022		September 30, 2021
Restricted Stock Units		1,000		1,000		327,715		257,400

Non-employee directors Restricted Stock Units (“RSUs”) typically vest over the earlier of one year or the next annual meeting of shareholders and Non-Qualified stock options vest over three years and have a six-year exercise period.  Employee RSUs typically vest over four years and employee Non-Qualified stock options typically vest quarterly over 4 years and have a six-year exercise period.

The remaining unamortized expected future equity compensation expense and remaining amortization period associated with unvested option grants, restricted stock awards and restricted stock unit awards at September 30, 2022 are:

	September 30, 2022
Unamortized future equity compensation expense (in thousands)	$	2,371
Remaining weighted average amortization period (in years)		2.64